DeWayne Townsend

Predominance of delta-opioid-binding sites in the porcine enteric nervous system.

Cannabinoids throw up a conundrum.

Characterization of specific opioid binding sites in neural membranes from the myenteric plexus of porcine small intestine.

Characterization of specific delta-opioid binding sites in the distal small intestine of swine.

Dystrophic heart failure blocked by membrane sealant poloxamer.

Mediation of neurogenic ion transport by acetylcholine, prostanoids and 5-hydroxytryptamine in porcine ileum.

Cardiomyopathy of Duchenne muscular dystrophy: pathogenesis and prospect of membrane sealants as a new therapeutic approach.

Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma.

Systemic administration of micro-dystrophin restores cardiac geometry and prevents dobutamine-induced cardiac pump failure.

Emergent dilated cardiomyopathy caused by targeted repair of dystrophic skeletal muscle.

Designing heart performance by gene transfer.

Artificial selection for whole animal low intrinsic aerobic capacity co-segregates with hypoxia-induced cardiac pump failure.

Cardiac consequences to skeletal muscle-centric therapeutics for Duchenne muscular dystrophy.

Molecular cardiology in translation: gene, cell and chemical-based experimental therapeutics for the failing heart.

Heparan sulfate Ndst1 regulates vascular smooth muscle cell proliferation, vessel size and vascular remodeling.

Chronic administration of membrane sealant prevents severe cardiac injury and ventricular dilatation in dystrophic dogs.

Distinct pathophysiological mechanisms of cardiomyopathy in hearts lacking dystrophin or the sarcoglycan complex.

Age-dependent dystrophin loss and genetic reconstitution establish a molecular link between dystrophin and heart performance during aging.

Cardiac involvement in the dystrophinopathies.

Exercise and muscular dystrophy: implications and analysis of effects on musculoskeletal and cardiovascular systems.

Alterations of dystrophin-associated glycoproteins in the heart lacking dystrophin or dystrophin and utrophin.

Finding the sweet spot: assembly and glycosylation of the dystrophin-associated glycoprotein complex.

Dystrobrevin increases dystrophin's binding to the dystrophin-glycoprotein complex and provides protection during cardiac stress.

Early right ventricular fibrosis and reduction in biventricular cardiac reserve in the dystrophin-deficient mdx heart.

Severe dystrophic cardiomyopathy caused by the enteroviral protease 2A-mediated C-terminal dystrophin cleavage fragment.

Early Detection of Myocardial Bioenergetic Deficits: A 9.4 Tesla Complete Non Invasive 31P MR Spectroscopy Study in Mice with Muscular Dystrophy.

Diastolic dysfunction precedes hypoxia-induced mortality in dystrophic mice.

Hypoxia-induced cardiac injury in dystrophic mice.